Gala GLP-1 GLP-1 Review (2026): Pricing, Coverage, and Tradeoffs

Item: Gala GLP-1
Author: RangeYourself

Gala GLP-1 review, semaglutide compounded, $149–$199/mo (verified 2026-07-14): $179/mo standard 'all doses', $199/mo on a 3-month plan, $149/mo microdosing. confirm the exact rate in enrollment., tirzepatide compounded glp-1/gip, from $179/mo; microdosing glp-1/gip $149/mo (verified 2026-07-14). confirm the exact rate in enrollment.. All-50-state compounded GLP-1 shoppers comparing cash-pay options. Independent 2026 review from RangeYourself.

By RangeYourselfLast verified 2026-07-14

Quick take

Gala GLP-1 is compounded glp-1 (semaglutide) and glp-1/gip, once-weekly at-home injection; microdosing option, priced as cash-pay subscription; recurring price advertised as a range across gala’s own pages ($149–$199/mo). Best for: All-50-state compounded GLP-1 shoppers comparing cash-pay options. Watch out for: Gala lists a range rather than one recurring price: $179/mo 'all doses' in the hero, $199/mo 'with a 3-month plan' in the FAQ, and $149/mo for microdosing, confirm the exact ongoing rate in enrollment.

Gala GLP-1 review: the microdosing program

Gala GLP-1 is a cash-pay compounded GLP-1 program whose defining feature is a microdosing plan. It discloses upfront that compounded GLP-1 is not FDA-approved and is sourced from licensed compounding pharmacies (Gala’s own wording), it bundles the medication into the monthly price with no separate membership fee, and, per its own site, it prescribes through licensed providers in all 50 states. The two things to weigh before enrolling are on the pricing summary below. Gala advertises a range of recurring prices across its own pages rather than one single number, and it does not name the pharmacy that fills your order.

What actually sets Gala apart: a microdosing option

Nationwide coverage is sometimes cited as Gala’s edge, but it is not a real differentiator, half the programs we track (12 of 24) already ship to all 50 states, so “available everywhere” does not distinguish Gala from the field. Gala’s genuine differentiator is that it offers a microdosing plan: a lower-dose GLP-1/GIP option priced below its standard tier (see the pricing summary). Only three programs in our registry advertise microdosing at all, which makes Gala worth a look if you and your prescriber decide a lower dose fits your plan, to start gently, hold a maintenance dose, or manage cost. Compare the options on our GLP-1 microdosing programs guide.

Pharmacy and testing transparency

Gala describes its fulfillment as “a wide network of pharmacies across all 50 states” but names no specific pharmacy and no 503A/503B status, and it makes no third-party lab-testing claim. That is common in this category, but it means you cannot verify the dispensing pharmacy in advance. If that matters to you, ask Gala support which pharmacy fills your order and request that pharmacy’s certificate of analysis for your batch, and see how Gala compares with peers on our compounded GLP-1 testing transparency page.

Pricing summary

Price verified: 2026-07-14 (checked against the provider’s public pricing surface)
All-in monthly cost: $149/month (medication included), advertised starting price
Semaglutide: Compounded, $149–$199/mo (verified 2026-07-14): $179/mo standard 'all doses', $199/mo on a 3-month plan, $149/mo microdosing. Confirm the exact rate in enrollment.
Tirzepatide: Compounded GLP-1/GIP, from $179/mo; microdosing GLP-1/GIP $149/mo (verified 2026-07-14). Confirm the exact rate in enrollment.
Compounded vs brand-name: Compounded only
Insurance accepted: No insurance-billing path published (cash-pay); confirm at signup
Consult type: Async questionnaire, per the provider’s published flow
Dose-escalation pricing: Advertised as a range across Gala’s own pages, $179/mo 'all doses' (hero), $199/mo on a 3-month plan (FAQ), $149/mo microdosing; confirm your rate in the enrollment flow.
Refund policy: Cancel the subscription anytime with 72h notice before billing; refunds are not issued on cancellation except for provider-side medical disqualification.
States served: All 50 US states + Washington, D.C.

Check Gala GLP-1 pricing →

Choose Gala GLP-1 if

You want compounded GLP-1 or GLP-1/GIP on a cash-pay plan available in all 50 states
You want a microdosing option ($149/mo)
You value an upfront 'not FDA-approved' compounding disclosure
You’re comfortable confirming the exact recurring rate in Gala’s enrollment flow

Skip Gala GLP-1 if

You want a single clearly-listed recurring price up front, a named 503A/503B pharmacy, or insurance billing.

Contraindications and clinical notes

Standard GLP-1 contraindications per GLP-1 prescribing information (personal/family history of MTC or MEN 2).. Talk to a clinician about personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or other conditions before starting any GLP-1 medication.

Verified programs that cost less than Gala GLP-1

Gala GLP-1’s own verified figure is $149/mo (advertised starting price). Every program below carries a lower all-in monthly price that we verified on the provider’s own pricing page, ranked lowest first as of September 3, 2026.

1.Embody
$69/mo (limited-time promo), verified August 21, 2026
See pricing →
2.Strut Health
$99/mo (sublingual/oral starting price), verified August 21, 2026
See pricing →
3.Trimi
$99/mo (annual-plan rate), verified August 21, 2026
See pricing →
4.HealthRX
$99/mo (12-month plan rate), verified August 21, 2026
See pricing →
5.bmiMD
$119/mo (12-month plan rate), verified September 3, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

How Gala GLP-1 compares

Frequently asked questions

How much does Gala GLP-1 cost per month?

Gala GLP-1's lowest verified rate is $149/month with compounded medication included. Semaglutide: Compounded, $149–$199/mo (verified 2026-07-14): $179/mo standard 'all doses', $199/mo on a 3-month plan, $149/mo microdosing. Confirm the exact rate in enrollment.; tirzepatide: Compounded GLP-1/GIP, from $179/mo; microdosing GLP-1/GIP $149/mo (verified 2026-07-14). Confirm the exact rate in enrollment.. Advertised as a range across Gala’s own pages, $179/mo 'all doses' (hero), $199/mo on a 3-month plan (FAQ), $149/mo microdosing; confirm your rate in the enrollment flow.

Does Gala GLP-1 accept insurance?

Gala GLP-1 publishes cash-pay prices and we found no insurance-billing path on its own site. Where a provider's own FAQ leaves the door open, the answer sits inside its intake flow, which we do not enter, so confirm at signup rather than treating this as settled. If you want insurance-billed brand-name GLP-1, see our list of GLP-1 programs that accept insurance.

What states does Gala GLP-1 serve?

Gala GLP-1 ships medication to all 50 US states plus Washington, D.C.

Is Gala GLP-1 compounded or brand-name?

Gala GLP-1 prescribes compounded semaglutide and tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

What's the catch with Gala GLP-1?

Gala lists a range rather than one recurring price: $179/mo 'all doses' in the hero, $199/mo 'with a 3-month plan' in the FAQ, and $149/mo for microdosing, confirm the exact ongoing rate in enrollment. Avoid if: you want a single clearly-listed recurring price up front, a named 503a/503b pharmacy, or insurance billing.

What the records show

Gala GLP-1 shows the same kind of split as Henry Meds: a strong Trustpilot average against an F BBB grade where every filed complaint went unanswered, the unresponsiveness, not just the complaint count, is what drives the F here.

Trustpilot: 4.6★ (3,893 reviews) via Trustpilot, checked 2026-07-24

RY lists Gala's evidence URL as galaglp1.com; Trustpilot resolves the same company's claimed profile under the galahealth.co domain.

BBB: F rating (not accredited), BBB profile, checked 2026-07-24

Listed as “AI Coaching Inc., d/b/a Gala GLP-1” (Wilmington, DE); 22 complaints, failure to respond to all of them, a wide gap from Gala's 4.6 Trustpilot score, both reported as observed.

Independently observed third-party data, not our own editorial score. Full methodology: GLP-1 Provider Reliability Report.

Related guides

Gala GLP-1 availability by state

GLP-1 programs in California , where Gala GLP-1 ships and how it stacks up locally.
GLP-1 programs in Texas , where Gala GLP-1 ships and how it stacks up locally.
GLP-1 programs in Florida , where Gala GLP-1 ships and how it stacks up locally.
GLP-1 programs in New York , where Gala GLP-1 ships and how it stacks up locally.
GLP-1 programs in Illinois , where Gala GLP-1 ships and how it stacks up locally.

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers verified on 2026-07-14 and may change.